Use of Single-Chain Antibody Derivatives for Targeted Drug Delivery

被引:36
|
作者
Safdari, Yaghoub [1 ,7 ]
Ahmadzadeh, Vahideh [2 ,3 ]
Khalili, Masoumeh [4 ]
Jaliani, Hossein Zarei [5 ]
Zarei, Vahid [6 ]
Erfani-Moghadam, Vahid [1 ,7 ]
机构
[1] Golestan Univ Med Sci, Med Cellular & Mol Res Ctr, Gorgan, Iran
[2] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Biotechnol Res Ctr, POB 5165665813, Tabriz, Iran
[4] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, POB 49341746110T, Gorgan, Iran
[5] Shahid Sadoughi Univ Med Sci, Sch Paramed, Dept Adv Med Sci & Technol, Yazd, Iran
[6] Shiraz Univ, Coll Sci, Dept Chem, Shiraz, Iran
[7] Golestan Univ Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Gorgan, Iran
关键词
POTENT ANTITUMOR-ACTIVITY; ANTIGEN-PRESENTING CELLS; BREAST-CANCER THERAPY; LUNG-CANCER; IMMUNE-RESPONSES; FUSION PROTEIN; SIRNA DELIVERY; IN-VIVO; ALBUMIN NANOPARTICLES; DENDRITIC CELLS;
D O I
10.2119/molmed.2016.00043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Single-chain antibodies (scFvs), which contain only the variable domains of full-length antibodies, are relatively small molecules that can be used for selective drug delivery. In this review, we discuss how scFvs help improve the specificity and efficiency of drugs. Small interfering RNA (siRNA) delivery using scFv-drug fusion peptides, siRNA delivery using scFv-conjugated nanoparticles, targeted delivery using scFv-viral peptide-fusion proteins, use of scFv in fusion with cell-penetrating peptides for effective targeted drug delivery, scFv-mediated targeted delivery of inorganic nanoparticles, scFv-mediated increase of tumor killing activity of granulocytes, use of scFv for tumor imaging, site-directed conjugation of scFv molecules to drug carrier systems, use of scFv to relieve pain and use of scFv for increasing drug loading efficiency are among the topics that are discussed here.
引用
收藏
页码:258 / 270
页数:13
相关论文
共 50 条
  • [1] Use of Single-Chain Antibody Derivatives for Targeted Drug Delivery
    Yaghoub Safdari
    Vahideh Ahmadzadeh
    Masoumeh Khalili
    Hossein Zarei Jaliani
    Vahid Zarei
    Vahid Erfani-Moghadam
    Molecular Medicine, 2016, 22 : 258 - 270
  • [2] Single-chain polymer nanoparticles in controlled drug delivery and targeted imaging
    Kroger, A. Pia P.
    Paulusse, Jos M. J.
    JOURNAL OF CONTROLLED RELEASE, 2018, 286 : 326 - 347
  • [3] Targeted gene delivery using humanized single-chain antibody with negatively charged oligopeptide tail
    Suzuki, M
    Takayanagi, A
    Shimizu, N
    CANCER SCIENCE, 2004, 95 (05): : 424 - 429
  • [4] Utilization of Single-Chain Antibody for Drug Discovery Application
    Matsukawa, Hiroaki
    Kakuda, Shinji
    Kikuchi, Asaka
    Yamamoto, Takashi
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 178A - 179A
  • [5] A SINGLE-CHAIN ANTIBODY
    JOUANNEAU, AC
    BIOFUTUR, 1987, (54) : 56 - 57
  • [6] Single-chain polypeptide: Universal module for targeted gene delivery
    Anisimova, VA
    Shemyakin, IG
    MOLECULAR THERAPY, 2004, 9 : S320 - S320
  • [7] Targeted inhibition of HBV gene expression by single-chain antibody mediated small interfering RNA delivery
    Wen, Wei-Hong
    Liu, Jia-Yun
    Qin, Wei-Jun
    Zhao, Jing
    Wang, Tao
    Jia, Lin-Tao
    Meng, Yan-Ling
    Gao, Hui
    Xue, Cai-Fang
    Jin, Bo-Quan
    Yao, Li-Bo
    Chen, Si-Yi
    Yang, An-Gang
    HEPATOLOGY, 2007, 46 (01) : 84 - 94
  • [8] Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodies
    An, Feng
    Drummond, Daryl C.
    Wilson, Shannon
    Kirpotin, Dmitri B.
    Nishimura, Stephen L.
    Broaddus, V. Courtney
    Liu, Bin
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (03) : 569 - 578
  • [9] Development of single-chain Fv of antibody to DNA as intracellular delivery vehicle
    Im, Sun-Woo
    Chung, Hee Yong
    Jang, Young-Ju
    ANIMAL CELLS AND SYSTEMS, 2017, 21 (06) : 382 - 387
  • [10] Recombinant single-chain antibodies with various oligopeptide tails for targeted gene delivery
    Suzuki, M
    Takayanagi, A
    Shimizu, N
    GENE THERAPY, 2003, 10 (09) : 781 - 788